(Circulation. 2003;108:2298.)
© 2003 American Heart Association, Inc.
Review: Current Perspective |
From the Division of Cardiology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, Calif (P.-S.C., H.S.K., S.-F.L.); the Division of Cardiology, Department of Medicine, Taichung Veterans General Hospital and Institute of Clinical Medicine, Cardiovascular Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan (T.-J.W., C.-T.T.); and the Cardiovascular Research Laboratory and Division of Cardiology, Department of Medicine, Center for Health Sciences, David Geffen School of Medicine at UCLA, Los Angeles, Calif (A.G., J.N.W.).
Correspondence to Peng-Sheng Chen, MD, Room 5342, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048. E-mail chenp{at}cshs.org
Key Words: death, sudden heart arrest electrophysiology arrhythmia drugs
| Introduction |
|---|
|
|
|---|
| Four Stages of VF |
|---|
|
|
|---|
Identification of these 4 stages of VF has significant clinical implications. Successful management of VF includes maneuvers both to prevent the onset of VF and to convert VF to sinus rhythm after VF occurs. The PVC suppression hypothesis, although proven to be ineffective,9 was based on the idea that suppressing the PVC initiating nonsustained ventricular tachycardia (VT) should eliminate stage I VF, hence preventing sudden death. The Restitution Hypothesis10 posits that the steepness of the APD restitution slope is a primary dynamic factor that predisposes cardiac waves to break. Therefore, flattening the APD restitution could both suppress the ability of the PVC to initiate stage 1 VF and prevent the conversion from stage I VF (VT) to stage II VF. Once stage II VF develops, electrical defibrillation is the most effective therapy. The implantable cardioverterdefibrillator (ICD) delivers therapies during stage II VF. Automatic external defibrillators, which deliver shocks within approximately 4 minutes after the onset of VF, likely are used during stages III and IV VF. Because the time from dispatch of paramedics to delivery of the first shock in victims of sudden death averages approximately 9 minutes, the majority of these shocks are delivered during stage IV VF.
Controversies in the Mechanisms of VF
Although it is clear that there are 4 stages of VF, there has been no unifying hypothesis to link all these observations together. Instead, with advances in multichannel computerized mapping techniques and optical mapping techniques, data collected from a wide range of animal models have led to apparently conflicting hypotheses on the mechanisms of VF. Most mapping studies show that VF is characterized by the coexistence of multiple wavefronts circulating throughout the ventricular myocardium. Because the individual waves have a finite lifespan,3 the hallmark of VF is the constant formation of new wavebreaks. The major controversy centers on whether these new wavebreaks are themselves responsible for the continuation of VF (the Multiple Wavelet Hypothesis), or are merely an epiphenomenon caused by a rapidly firing focal source, which the bulk of the cardiac tissue cannot follow with 1:1 conduction (the Focal Source Hypothesis).
Multiple Wavelet Hypothesis
Moe et al11 hypothesized that the constant formation of new wavelets occurs through the process of wave splitting (wavebreak), resulting in multiple wavelet fibrillation. The wave splitting occurs because of nonuniform dispersion of refractoriness and anatomic heterogeneity. Nonuniform dispersion of refractoriness naturally occurs in the normal myocardium as a result of transmural and base-to-apex heterogeneity of action potential durations12 and is further exacerbated by disease. The anatomic heterogeneities, which are naturally present, also facilitate conduction blocks and wavebreaks through the source-sink mismatches.13 For example, epicardial coronary arteries,14 papillary muscles,15 transmural sites with abrupt fiber orientation changes,16 and increased fibrosis resulting from cardiomyopathy17 can all serve as sites of wavebreaks. With the more recent appreciation that dynamic factors related to electrical restitution also play a key role in facilitating wavebreak, an updated version of the Multiple Wavelet Hypothesis emphasizes that the synergy between dynamic factors and preexisting tissue heterogeneities are the fundamental cause of wavebreaks perpetuating VF.18
Focal Source Hypothesis
A competing hypothesis of VF is the Focal Source Hypothesis. This hypothesis posits that a single, rapidly firing focal source (reentrant or automatic) is the fundamental driver of VF, and that the multiple wavelets that characterize VF are an epiphenomena caused by "fibrillatory conduction block" because impulses from the rapid focus are unable to conduct 1:1 into the surrounding tissue. Gray et al19 first demonstrated that a single meandering spiral wave could underlie polymorphic VT resembling VF. Subsequently, studies from Jalifes group have proposed that a single rapidly firing reentrant scroll wave (rotor) is the mechanism underlying VF. For example, Samie et al20 studied Langendorff-perfused guinea pig hearts and showed that the highest frequency region (25 to 32 Hz) was always located on the anterior left ventricular wall and resulted from persistent rotor activity. Fibrillatory conduction blocks at specific locations in the periphery of the rotor were responsible for the organization of discrete dominant-frequency domains over the ventricular surface. Zaitsev et al21 performed Fourier analysis of VF in sheep ventricular tissue slabs. They observed that the frequency domain patterns were relatively stable and could persist from several seconds to several minutes. This observation prompted the authors to suggest that the underlying mechanism of VF could be a sustained intramural reentrant source interacting with tissue heterogeneities.
The focal source hypothesis of VF has potentially important clinical implications. If a single mother rotor or mother focus underlies the mechanisms of VF, then catheter ablation of the single focus could cure the arrhythmia. Compatible with this prediction, Haissaguerre et al22 successfully performed radiofrequency ablation in 27 patients with idiopathic VF characterized by rapid electrical discharges originating from foci in the distal Purkinje system. In summary, these data strongly support the notion that a rapid-firing focal source can result in fibrillatory conduction and VF in both animal models and in humans. The extent to which these observations apply to the majority of cases of VF causing sudden cardiac death in humans, however, remains unclear.
New Evidence in Support of Multiple Wavelet Hypothesis
Although recent evidence for the focal source hypothesis in the experimental models studied by Jalife and coworkers has been compelling, investigators using different experimental VF models have obtained different results. Choi et al23 examined VF in guinea pig hearts and found that local velocity vectors during VF showed no preferential directions, and that fast Fourier transform power spectra were broad with multiple peaks, making determination of dominant frequency equivocal. Valderrabano et al24 examined VF in arterially perfused porcine ventricle and failed to find evidence of stationary-dominant frequency domains indicative of fibrillatory conduction block. In another study, Choi et al25 showed that VF consists of dynamically changing frequency blobs, which have a short lifespan and can be modified by pharmacological interventions, suggesting that VF is maintained by dynamically changing multiple wavelets.
In their letters to the editors of Circulation Research,26,27 2 of these groups suggested that studies published by the opposing group had errors in experimental procedures, data analyses, and data interpretation. The strong convictions of these highly experienced investigators are evident from reading the concluding statements of those letters.26,27 However, another possibility is that they were studying different types of VF. If 2 different types of VF can coexist in the same heart, then a resolution to this heated debate on the mechanism of VF could be at hand.
Two Types of VF
We1 performed a study in Langendorff-perfused rabbit hearts to test the hypothesis that 2 types of VF resulting from different mechanisms can coexist in the same heart under different conditions. The study used optical mapping to determine VF activation patterns at baseline and during methoxyverapamil (D600) infusion. In additional experiments, we tested the effects of a low concentration of D600 plus a sodium channel blocker, tetrodotoxin (TTX). At baseline, the activation rate was fast, and the dominant frequency of VF was approximately 18 Hz. D600 flattened the APD restitution curve and converted baseline fast (type I) VF to VT at a concentration of 0.5 mg/L. This observation is not surprising because other drugs that flatten APD restitution slope also convert VF to VT in different animal models.10,28 However, further increasing the D600 concentration to 2.5 or 5.0 mg/L converted VT to slow (type II) VF with an average dominant frequency of approximately 11 Hz.
Because high concentrations of D600 block Na channels as well as Ca channels, we hypothesized that reduced excitability might underlie type II VF. To test the latter hypothesis, we gave TTX during VT induced by a low concentration of D600. TTX also converted VT to type II VF. Optical maps showed that wavebreaks occurred during both types of VF. However, unlike type I VF with steep APD restitution slope, during type II VF, the APD restitution slope was flat. Therefore, type II VF was not driven by steep APD restitution, but was the result of another factor related to reduced excitability. The other factor turned out to be the other component of electrical restitution, CV restitution. Although APD restitution slope was flat in type II VF, CV, estimated from the inverse of conduction time, varied widely over a broad range of diastolic intervals as a result of low excitability, ie, the CV restitution curve was broad. It makes sense that broad CV restitution promotes wavebreak, because electrical wavelength is the product of APD · CV. Whereas steep APD restitution drives wave instability by making the waveback sensitive to small changes in diastolic interval, CV can drive wave instability by making the wavefront sensitive to small changes in diastolic interval, especially if structural and electrophysiological heterogeneities are present. Computer simulations29 showed that without CV restitution, CV is essentially constant throughout the tissue during rapid pacing. Therefore, the arrival time of an impulse at a given distance from the pacing site has no way to vary between successive beats, assuming no change of the conduction pathway. In situations with flat APD restitution, broad CV restitution is primarily responsible for magnifying spatial variations in cycle length and DI. When the excitability is reduced by D600 or TTX, the low safety factor for propagation can cause local propagation failure when wavefront emanating from a mother focus encounters regions of disparate intrinsic refractoriness after short DIs.
An important finding of this study1 is that as D600 concentration was increased, type I VF converted to sustained monomorphic VT before type II VF appeared. The VT stage occurred because APD restitution had become flat, but excitability was still high. The intermediate VT stage strongly supports the idea that the 2 types of VF are distinct entities as a result of different mechanisms rather than a gradual reduction of the activation rate of the same VF resulting from reduced excitability. On the basis of these findings, we concluded that 2 types of VF can coexist in the same isolated rabbit ventricle. Type I VF is associated with steep APD restitution, flat CV restitution, and wandering wavelets. Type II VF is associated with flat APD restitution slope and broad CV restitution as a result of low excitability. The flat APD restitution inhibits spiral wave breakup, and in the setting of preexisting tissue heterogeneity, allows the fastest spiral wave to be stable enough to overdrive slower spiral waves and become the "mother rotor." Epicardial activation maps show spatiotemporal periodicity compatible with the activation originating from a fast focal source. Because of reduced excitability and preexisting tissue heterogeneity, however, fibrillatory conduction block occurs in surrounding tissue, resulting in occasional wavebreaks that gave the electrocardiogram a morphology characteristic of VF. This scenario is consistent with observations of other investigators30 who have also showed that both APD restitution and CV restitution are important in the maintenance of arrhythmias in rabbit ventricles.
In summary, type I VF is consistent with VF resulting from a multiple wavelet mechanism. Although occasional reentry is observed, none persists long enough to qualify as a constant focal source of VF. This VF in general is characterized by changing patterns of activation from moment to moment. These findings are consistent with the results of Choi et al23,25 and Valderrabano et al24 and resemble the VF activation patterns seen in large animals.5,6 On the other hand, type II VF is characterized by large and repeatable patterns of epicardial activations with occasional wavebreaks. These patterns of VF are consistent with those reported by Gray et al31 and Chen et al,32 who found significant spatiotemporal organization during fibrillation, suggesting that an ongoing focal and relatively stable source is the engine of VF. Taken together, we propose that VF associated with steep APD restitution but flat CV restitution (normal excitability) has different patterns of activation than VF associated with flat APD restitution with broad CV restitution (low excitability). If different investigators have been studying different types of VF, this could account for their drastically different interpretations.
Other Factors Important in the Maintenance of VF
In addition to electrical restitution, other factors also contribute to the development and evolution of VF. Cell coupling, for example, is also an important determinant of CV33 and might be important in the generation of conduction block and reentry. On the other hand, good intercellular coupling could facilitate spontaneous defibrillation.34 It is possible that abnormal cell coupling can reduce excitability and broaden CV restitution sufficiently to produce type II VF. The intracellular Ca cycling also has important effects on wavelength, which could contribute to degeneration of VT to VF.35
Two Types of VF in Sudden Cardiac Death
To speculate on how these observations could relate to clinical episodes of sudden cardiac death in patients, Taggart36 reported that acute ventricular ischemia results in both APD shortening and flattening of APD restitution slope in human patients. In addition, excitability progressively decreases during acute ischemia. The onset of VF immediately leads to global acute ischemia as a result of circulatory arrest. Thus, type I VF normally inexorably leads to type II VF. This is illustrated in Figure 1 by a Holter recording during an episode of sudden cardiac death. The initial fine VF was fast, compatible with type I VF. After a few minutes, the VF cycle length lengthened, reflecting the conversion of type I (fast) VF to type II (slow) VF (arrow) as acute global ischemia flattened APD restitution, reduced excitability, and promoted increased tissue heterogeneity.
|
In contrast, spontaneous defibrillation occasionally occurs in humans. Figure 2 shows an example. The spontaneous VF episode here is compatible with type I VF with rapid, fractionated electrograms, and terminated spontaneously before there was any substantial slowing in the electrographic appearance as a result of the effects of acute global ischemia. Thus, VF reverted spontaneously in the type I VF stage and sudden death was aborted. By flattening APD restitution,36 acute global ischemia could initially be antifibrillatory and help to prevent perpetuation of type I VF10 before the effects of low excitability set in to promote further wavebreak. Note the increased sinus rate after spontaneous defibrillation, suggesting elevated sympathetic activity. Others34 have suggested that increased myocardial catecholamine content facilitates self-defibrillation. One possibility is that catecholamines, which increase excitability, could enhance the probability of self-defibrillation by delaying the conversion from type I VF to type II VF, or delaying the decrease in excitability during type II VF. This latter hypothesis is supported by the observation that during cardiopulmonary resuscitation, the probability of successful defibrillation can be enhanced by epinephrine injection.37 Type II VF can be intrinsically more difficult to defibrillate than type I VF, because in type II VF, wavefronts emerging after the shock are much more likely to break up as a result of low excitability and reinitiate VF. Another important factor in favor of self-defibrillation in this patient might be the absence of coronary artery diseases. Without preexisting regional ischemia, flattening of APD restitution slope during acute global ischemia could have helped to terminate type I VF spontaneously before reduced excitability converted it into type II VF. Patients with Brugada syndrome are known to have repeated aborted sudden cardiac death as a result of nonsustained VF. The absence of structural heart disease, and specifically coronary artery disease, might also contribute to the self-defibrillation in these patients.
|
Finally, these observations could help to account for the deleterious effects of class I antiarrhythmic drugs on mortality in patients at increased risk of sudden cardiac death. By blocking Na channels, these drugs reduce excitability and accelerate the conversion of type I to type II VF.
Two Types of VF and Resuscitation
The existence of 2 types of VF has significant implications for cardiopulmonary resuscitation. Weisfeldt and Becker38 proposed that cardiac arrest has 3 time-sensitive phases, the electrical phase (0 to 4 minutes), the circulatory phase (4 to 10 minutes), and the metabolic phase (>10 minutes). During the electrical phase, immediate defibrillation has a high success rate, which is characteristic of type I VF. As ischemia progresses, however, electrical defibrillation has a lower success rate unless chest compressions are first applied for several minutes. This is consistent with the transition to type II VF as excitability progressively decreases due to accumulation of ischemic metabolites. Type II VF is more difficult to defibrillate because low excitability promotes new wavebreaks postshock. By restoring some coronary blood flow and washing out ischemic metabolites, chest compressions improve excitability and thereby enhance defibrillation success rate. In the metabolic phase, however, resuscitation efforts should be metabolically focused.
| Conclusions |
|---|
|
|
|---|
On the opposite end of the spectrum are patients with structurally normal hearts. Their higher rate of spontaneous recovery from VF could in part be facilitated by acute global ischemia on flattening APD restitution, providing a window of opportunity for self-defibrillation before progressive ischemia reduces excitability and converts type I to lethal type II VF. The challenge for the future is to develop effective therapy to prevent both the initiation of type I VF and its conversion to type II VF. Therapeutics designed to modify electrical restitution properties, including both APD and CV restitution, could hold one of the keys.
| Acknowledgments |
|---|
This study was supported in part by Yen-Tjing-Ling Medical Foundation, Taipei, Taiwan; by National Institutes of Health grants R01HL58533, R01HL58241, P50HL52319, R01HL66389, R01HL71140, Bethesda, Md; and by Laubisch, Kawata, and Pauline and Harold Price Endowments, Los Angeles, Calif. The authors thank Jeffrey S. Goodman, MD, and C. Thomas Peter, MD, for providing the Holter recordings shown in Figures 1 and 2
, respectively. They also thank Elaine Lebowitz for her assistance.
| References |
|---|
|
|
|---|
2. Wiggers CJ, Bell JR, Paine M. Studies of ventricular fibrillation caused by electric shock. II. Cinematographic and electrocardiographic observation of the natural process in the dogs heart. Its inhibition by potassium and the revival of coordinated beats by calcium. Am Heart J. 1930; 5: 351365.[CrossRef]
3. Chen P-S, Wolf PD, Dixon EG, et al. Mechanism of ventricular vulnerability to single premature stimuli in open-chest dogs. Circ Res. 1988; 62: 11911209.
4. Bonometti C, Hwang C, Hough D, et al. Interaction between strong electrical stimulation and reentrant wavefronts in canine ventricular fibrillation. Circ Res. 1995; 77: 407416.
5. Lee JJ, Kamjoo K, Hough D, et al. Reentrant wave fronts in Wiggers stage II ventricular fibrillation: characteristics, and mechanisms of termination and spontaneous regeneration. Circ Res. 1996; 78: 660675.
6. Rogers JM, Huang J, Smith WM, et al. Incidence, evolution, and spatial distribution of functional reentry during ventricular fibrillation in pigs. Circ Res. 1999; 84: 945954.
7. Worley SJ, Swain JL, Colavita PG, et al. Development of an endocardial-epicardial gradient of activation rate during electrically induced sustained ventricular fibrillation in dogs. Am J Cardiol. 1985; 55: 813820.[CrossRef][Medline] [Order article via Infotrieve]
8. Cha Y-M, Uchida T, Wolf PL, et al. Effects of chemical subendocardial ablation on activation rate gradient during ventricular fibrillation. Am J Physiol. 1995; 269: H1998H2009.[Medline] [Order article via Infotrieve]
9. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991; 324: 781788.[Abstract]
10. Garfinkel A, Kim Y-H, Voroshilovsky O, et al. Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci U S A. 2000; 97: 60616066.
11. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther. 1962; 140: 183188.
12. Antzelevitch C, Sicouri S, Litovsky SH, et al. Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res. 1991; 69: 14271449.
13. Valderrabano M, Chen PS, Lin SF. Spatial distribution of phase singularities in ventricular fibrillation. Circulation. 2003; 108: 354359.
14. Pertsov AM, Davidenko JM, Salomonsz R, et al. Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res. 1993; 72: 631650.
15. Kim Y-H, Xie F, Yashima M, et al. Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle. Circulation. 1999; 100: 14501459.
16. Valderrábano M, Lee M-H, Ohara T, et al. Dynamics of intramural and transmural reentry during ventricular fibrillation in isolated swine ventricles. Circ Res. 2001; 88: 839848.
17. Wu T-J, Ong JJ, Hwang C, et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J Am Coll Cardiol. 1998; 32: 187196.
18. Weiss JN, Garfinkel A, Karagueuzian HS, et al. Chaos and the transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation. Circulation. 1999; 99: 28192826.
19. Gray RA, Jalife J, Panfilov AV, et al. Mechanisms of cardiac fibrillation. Science. 1995; 270: 12221223.
20. Samie FH, Berenfeld O, Anumonwo J, et al. Rectification of the background potassium current: a determinant of rotor dynamics in ventricular fibrillation. Circ Res. 2001; 89: 12161223.
21. Zaitsev AV, Berenfeld O, Mironov SF, et al. Distribution of excitation frequencies on the epicardial and endocardial surfaces of fibrillating ventricular wall of the sheep heart. Circ Res. 2000; 86: 408417.
22. Haissaguerre M, Shoda M, Jais P, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation. 2002; 106: 962967.
23. Choi BR, Liu T, Salama G. The distribution of refractory periods influences the dynamics of ventricular fibrillation. Circ Res. 2001; 88: E49E58.[Medline] [Order article via Infotrieve]
24. Valderrábano M, Yang J, Omichi C, et al. Frequency analysis of ventricular fibrillation in Swine ventricles. Circ Res. 2002; 90: 213222.
25. Choi BR, Nho W, Liu T, et al. Life span of ventricular fibrillation frequencies. Circ Res. 2002; 91: 339345.
26. Berenfeld O, Pertsov AM, Jalife J. What is the organization of waves in ventricular fibrillation? Circ Res. 2001; 89: E22.[Medline] [Order article via Infotrieve]
27. Choi BR, Liu T, Salama G. Ventricular fibrillation: mother rotor or multiple wavelets? Circ Res. 2001; 89: E30.[Medline] [Order article via Infotrieve]
28. Riccio ML, Koller ML, Gilmour RFJ. Electrical restitution and spatiotemporal organization during ventricular fibrillation. Circ Res. 1999; 84: 955963.
29. Cao J-M, Qu Z, Kim Y-H, et al. Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. Circ Res. 1999; 84: 13181331.
30. Banville I, Gray RA. Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J Cardiovasc Electrophysiol. 2002; 13: 11411149.[CrossRef][Medline] [Order article via Infotrieve]
31. Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization during cardiac fibrillation. Nature. 1998; 392: 7578.[CrossRef][Medline] [Order article via Infotrieve]
32. Chen J, Mandapati R, Berenfeld O, et al. High-frequency periodic sources underlie ventricular fibrillation in the isolated rabbit heart. Circ Res. 2000; 86: 8693.
33. Rohr S, Kucera JP, Kleber AG. Slow conduction in cardiac tissue, I: effects of a reduction of excitability versus a reduction of electrical coupling on microconduction. Circ Res. 1998; 83: 781794.
34. Manoach M, Watanabe Y. How can we facilitate spontaneous termination of ventricular fibrillation and prevent sudden cardiac death? A working hypothesis. J Cardiovasc Electrophysiol. 1995; 6: 584589.[Medline] [Order article via Infotrieve]
35. Chudin E, Goldhaber J, Garfinkel A, et al. Intracellular Ca(2+) dynamics and the stability of ventricular tachycardia. Biophys J. 1999; 77: 29302941.[Medline] [Order article via Infotrieve]
36. Taggart P, Sutton PM, Boyett MR, et al. Human ventricular action potential duration during short and long cycles. Rapid modulation by ischemia. Circulation. 1996; 94: 25262534.
37. Suddath WO, Deychak Y, Varghese PJ. Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation. Ann Emerg Med. 2001; 38: 201206.[CrossRef][Medline] [Order article via Infotrieve]
38. Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA. 2002; 288: 30353038.
This article has been cited by other articles:
![]() |
C. L. del Rio, T. A. Dawson, B. D. Clymer, D. J. Paterson, and G. E. Billman Effects of acute vagal nerve stimulation on the early passive electrical changes induced by myocardial ischaemia in dogs: heart rate-mediated attenuation Exp Physiol, August 1, 2008; 93(8): 931 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Tabereaux, G. P. Walcott, J. M. Rogers, J. Kim, D. J. Dosdall, P. G. Robertson, C. R. Killingsworth, W. M. Smith, and R. E. Ideker Activation Patterns of Purkinje Fibers During Long-Duration Ventricular Fibrillation in an Isolated Canine Heart Model Circulation, September 4, 2007; 116(10): 1113 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Huizar, M. D. Warren, A. G. Shvedko, J. Kalifa, J. Moreno, S. Mironov, J. Jalife, and A. V. Zaitsev Three distinct phases of VF during global ischemia in the isolated blood-perfused pig heart Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1617 - H1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Ideker and J. M. Rogers Human Ventricular Fibrillation: Wandering Wavelets, Mother Rotors, or Both? Circulation, August 8, 2006; 114(6): 530 - 532. [Full Text] [PDF] |
||||
![]() |
M. P. Nash, A. Mourad, R. H. Clayton, P. M. Sutton, C. P. Bradley, M. Hayward, D. J. Paterson, and P. Taggart Evidence for Multiple Mechanisms in Human Ventricular Fibrillation Circulation, August 8, 2006; 114(6): 536 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qu Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H255 - H263. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Weiss, Z. Qu, P.-S. Chen, S.-F. Lin, H. S. Karagueuzian, H. Hayashi, A. Garfinkel, and A. Karma The Dynamics of Cardiac Fibrillation Circulation, August 23, 2005; 112(8): 1232 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-m. Hwang, T. Y. Kim, and K. J. Lee From The Cover: Complex-periodic spiral waves in confluent cardiac cell cultures induced by localized inhomogeneities PNAS, July 19, 2005; 102(29): 10363 - 10368. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Holden The fine-scale architecture of defibrillation Cardiovasc Res, December 1, 2004; 64(3): 384 - 386. [Full Text] [PDF] |
||||
![]() |
T.-J. Wu, S.-F. Lin, A. Baher, Z. Qu, A. Garfinkel, J. N. Weiss, C.-T. Ting, and P.-S. Chen Mother Rotors and the Mechanisms of D600-Induced Type 2 Ventricular Fibrillation Circulation, October 12, 2004; 110(15): 2110 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Taneja, G. Horvath, D. K. Racker, D. Johnson, J. Goldberger, and A. Kadish Is there a correlation between ventricular fibrillation cycle length and electrophysiological and anatomic properties of the canine left ventricle? Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H823 - H832. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Efimov, V. P. Nikolski, and G. Salama Optical Imaging of the Heart Circ. Res., July 9, 2004; 95(1): 21 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Zipes The year in electrophysiology J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1306 - 1314. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |